Published: April 2025 | Last updated: May 2026
What are the signs of chlamydia, and how would I actually know I have it?
The common signs are unusual discharge, burning when you urinate, a pelvic or testicular ache, and bleeding after sex or between periods. But around 80% of women and 50% of men feel nothing at all. The only reliable answer is a test taken at least 14 days after exposure.
Chlamydia is one of the most commonly reported bacterial STIs in the United States, partly because it is so easy to miss. Around 80% of women and 50% of men who carry it have no noticeable symptoms at all, according to the NIH InformedHealth review of chlamydia. When something does feel off, it tends to be subtle: a brief sting when urinating, cloudy discharge, a dull pelvic ache that comes and goes, or light spotting after sex. Easy to chalk up to dehydration, a yeast issue, period changes, or stress.
If you landed here with burning when you pee or discharge that seems off, the honest first thing to know is that most cases of these symptoms are not chlamydia. UTIs, yeast, hormonal shifts, and bacterial vaginosis are far more common causes. The only way to be certain, though, is to rule out infection with a test. This guide walks through what chlamydia actually feels like in the body, why so many cases stay hidden, how presentations differ in men and women, when and how to test, and what to do if a result comes back positive. The good news first: this infection is curable with a short course of antibiotics. The harder part is knowing it is there in the first place.
Why chlamydia stays silent in most people
Chlamydia hides for a biological reason. Chlamydia trachomatis, the bacterium responsible, is an obligate intracellular pathogen. It lives and replicates inside your body's own cells rather than free in surrounding tissue. That intracellular lifestyle is precisely what lets it evade the kind of fast, obvious immune response that makes you feel sick. The infection replicates quietly while you go about your life, and it stays transmissible to partners the entire time.
Roughly 80% of women and 50% of men with chlamydia experience no noticeable symptoms throughout the infection, per the NIH InformedHealth chlamydia review. Even in the group where symptoms are more likely (men), half of all infections still produce nothing noticeable. For women, four out of five infections stay completely silent.
This is why the CDC recommends routine chlamydia screening for all sexually active women under 25 and for older women with new or multiple partners. Per CDC 2024 surveillance data, reported chlamydia cases declined about 8% from 2023, the second consecutive year of improvement. Chlamydia remains the most commonly reported bacterial STI in the country, and the decline reflects more screening reaching the people most likely to be infected, not lower underlying risk.
Younger people carry the highest infection rates, particularly sexually active women aged 15 to 24 and men who have sex with men. Consistent condom use lowers transmission risk substantially, though it does not eliminate it, especially for the oral and perianal contact that condoms do not cover.
The CDC recommends annual chlamydia screening for: sexually active women under 25; older women with new or multiple partners or a partner with an STI; all pregnant patients (with rescreening in the third trimester if under 25 or at continued risk); men who have sex with men; and anyone whose partner has tested positive. Anyone with new burning, discharge, pelvic pain, or spotting should also screen, regardless of age (<a href="https://www.cdc.gov/std/treatment-guidelines/chlamydia.htm" target="_blank" rel="noopener noreferrer">CDC Treatment Guidelines</a>).
The symptoms most people miss
When chlamydia does show up, it usually shows up quietly rather than dramatically. Below are the five most commonly reported signals, drawn from CDC and NHS clinical descriptions.
1. Burning when you pee
A short stinging or burning sensation during urination is one of the earliest signs. It happens because the bacteria infect the urethra, the tube that carries urine out of the body, and inflame the surrounding tissue. Clinicians sometimes call this presentation non-gonococcal urethritis, or NGU, in men. The catch: it feels almost identical to a urinary tract infection. People often try water, cranberry, and waiting it out for a week or two before considering an STI test (NHS, Chlamydia).
2. Discharge that looks a little off
People with vaginas may notice discharge that is cloudy, slightly yellow, or thicker than their usual baseline. It might feel slightly different, have a faint unfamiliar odor, or be just enough off to second-guess. People with penises sometimes see a small amount of milky or clear fluid near the tip of the penis, often most visible in the morning or when they have not recently urinated. Because discharge is not something men normally experience, even a small amount within a few weeks of a possible exposure is clinically significant.
3. Pelvic ache or testicular tenderness
If chlamydia spreads beyond the urethra, it can irritate deeper reproductive tissue. For people with a uterus, this often shows up as a dull lower-abdominal pressure or cramping that does not match the usual menstrual pattern. For people with testicles, it can cause swelling or pain in one testicle, a condition called epididymitis, which inflames the coiled tube running along the back of each testicle. The discomfort is rarely sharp, which is exactly why it gets dismissed as a pulled muscle, period cramps, or sitting wrong.
4. Pain during or after sex
Chlamydia can inflame the cervix and surrounding tissue, which makes intercourse uncomfortable or painful. Some people describe a deep internal pressure during penetration. Others notice soreness or light bleeding afterward. Pain during sex has plenty of non-STI causes (dryness, hormones, stress), so it rarely triggers an immediate STI thought, but it is a documented chlamydia signal worth taking seriously when it appears alongside other symptoms.
5. Spotting between periods or after sex
Cervical inflammation can also cause unexpected light bleeding outside a normal period. One episode after rough sex is usually nothing. A pattern of spotting between cycles, especially paired with discharge or pelvic ache, is a strong reason to test.
Where chlamydia hides beyond the genitals
Most people picture chlamydia as a genital infection. The bacterium infects mucous membranes, though, and those exist in more places than the genitals. The throat, the rectum, and (less often) the eyes can all carry an active infection. In most of those sites, there is no symptom at all, which makes them among the most consistently missed presentations in routine sexual-health care.
Throat chlamydia usually follows oral sex with an infected partner. The large majority of throat infections are silent; when anything shows up, it tends to be a mild sore throat that feels like a minor cold or post-nasal drip. Standard panels do not include a throat swab unless you specifically ask for one.
Rectal chlamydia follows the same pattern, typically after receptive anal sex, though it can occasionally spread from a genital infection without anal contact. Symptoms, when present, include rectal discomfort, a mucus-like discharge, or bleeding, and they are often mistaken for hemorrhoids. More often there is nothing to notice, and urine-based testing misses rectal infection entirely.
Eye involvement (chlamydial conjunctivitis) is uncommon in adults but can happen when infected secretions reach the eye, directly or on hands. It causes redness, irritation, and watery or pus-like discharge, and it is easy to mistake for ordinary conjunctivitis.
This matters for how you test. A throat or rectal infection needs a clinician-collected swab and lab processing, which a self-collected home genital swab cannot provide.
This article is published by stdrapidtestkits.com, which sells at-home STI testing kits; we recommend products based on fit for the reader's concern, not commercial benefit. Our rapid lateral-flow kit screens for genital-site chlamydia from a self-collected swab. For a throat or rectal exposure, a clinic-collected swab and lab NAAT is required, so ask specifically for pharyngeal or rectal testing when you book.
When symptoms appear, and when they don't
Timing is the single most confusing aspect of chlamydia for most people. Many expect symptoms to land within a day or two of exposure. In reality, the bacterium takes time to colonize and provoke a response.
The general window: most people who do develop symptoms notice them between 7 and 21 days after exposure. Some people feel a brief flare that fades, leaving them to assume the issue resolved on its own. Others stay symptom-free for months while the infection quietly continues.
Incubation window and testing window are related but different. Symptoms reflect your immune system beginning to respond. The testing window reflects when there is enough bacterial material in your sample to trigger a positive result, which is roughly 14 days after exposure. Someone might notice mild symptoms at day 10 and still test inconclusive at that point because the bacterial load has not yet reached the detection threshold. Test at 14 days regardless of how you feel.
This delay also creates a ripple effect for partners. Someone exposed in early March who develops a faint burning sensation in late March may not connect the events, and they may pass the infection to a new partner during the symptomless gap.
| Time after exposure | Likelihood of symptoms | Testing notes |
|---|---|---|
| 0 to 3 days | Very low | Bacterial load usually too low for reliable detection |
| 4 to 7 days | Low | Some lab NAAT tests may detect early infection |
| 7 to 14 days | Rising | Detection improving; retest after day 14 if negative |
| 14 to 21 days | Moderate to high if symptomatic | Peak detection window for both lab NAAT and at-home rapid swab |
| 21 days to months | Variable | Symptoms can fade while the infection persists; test if any uncertainty remains |
When chlamydia mimics something else
Chlamydia overlaps heavily with several other common conditions: urinary tract infections, yeast infections, bacterial vaginosis, herpes, and especially gonorrhea. Many people receive repeat treatments for one of these before anyone runs an STI panel. That delay is one of the more frustrating patterns in sexual-health care, and it is worth knowing how the conditions differ.
Gonorrhea is the closest clinical look-alike. Both infections target the same sites, produce similar discharge, and cause identical urinary symptoms. Even clinicians cannot reliably distinguish them without testing. Co-infection with gonorrhea is common enough that combination testing for both is standard when either is suspected, and testing for chlamydia alone while gonorrhea goes undetected is a frequent reason people think they have been reinfected when they were never fully treated to begin with.
Bacterial vaginosis can produce a cloudy, watery discharge with a fishy odor that is easy to mistake for early chlamydia. Yeast infections are usually more distinct: thick, white, cottage-cheese-like discharge with intense external itching. A UTI and urethral chlamydia both cause burning, but a UTI typically adds strong urgency and frequency, sometimes with fever. Herpes produces visible blisters or ulcers, which chlamydia does not.
| Condition | Discharge | Urinary symptoms | Distinguishing features |
|---|---|---|---|
| Chlamydia | Cloudy, white, pale yellow, watery, or none | Burning, mild, or none | Often completely silent; pelvic pain if advancing |
| Gonorrhea | Thicker, more noticeable, yellow-green | Burning, often more pronounced | Frequently co-occurs with chlamydia; clinically indistinguishable without testing |
| UTI | Usually none | Strong burning, urgency, frequency | May cause fever, cloudy urine; bacteria in the bladder rather than the urethra or cervix |
| Yeast infection | Thick, white, clumpy (cottage-cheese texture) | Mild burning possible | Intense external itching, redness; not sexually transmitted |
| Bacterial vaginosis | Gray-white, watery, fishy odor | Usually none | Not sexually transmitted; no partner treatment required |
| Genital herpes (HSV) | Usually none | Burning if urethra affected | Visible blisters, sores, or ulcers; lesions distinguish it from chlamydia |
What untreated chlamydia can do
This is where the silent reputation gets serious. Chlamydia is curable, but only if it is diagnosed. Left untreated, the bacterium can travel from the cervix or urethra into deeper reproductive tissue and stay there for months, causing damage that does not reverse easily.
For people with a uterus, the most common complication is pelvic inflammatory disease (PID). PID is inflammation of the uterus, fallopian tubes, and surrounding tissue, and it can cause scarring of the fallopian tubes, ectopic pregnancy, and infertility (CDC, About Pelvic Inflammatory Disease). The CDC estimates that about 1 in 8 women with a history of PID later have difficulty getting pregnant. Symptoms of PID can be mild at first (a low-grade pelvic ache, irregular bleeding) or severe (fever, sharp pain, painful intercourse), and the damage can occur even when the chlamydia itself was never noticeable, because PID can be silent in its early stages too.
For people with testicles, untreated chlamydia can cause epididymitis, a painful swelling of the tube behind each testicle. In rare cases this affects fertility. Prostatitis (pelvic discomfort with urinary symptoms) is another possible complication, and proctitis, inflammation of the rectum, can develop with rectal infection.
Untreated chlamydia also raises the risk of acquiring or transmitting HIV. Mucosal inflammation in the genital tract gives HIV easier access, which is part of why STI control matters as a public-health lever (WHO, Chlamydia Fact Sheet).
Reactive arthritis, a less common complication, can develop in the weeks after primary infection, with joint inflammation alongside eye or urethral symptoms. It is uncommon but real. None of this is meant to alarm anyone reading after a recent exposure. The infection responds quickly to antibiotics, and the risk accumulates over months of unrecognized infection, not days.
Test sooner rather than later if any of the following apply: a partner tested positive, a condom broke, you have new burning, discharge, or pelvic pain, you started spotting between periods, or you simply have not screened since changing partners.
How testing works, and how at-home kits compare
Two testing technologies do most of the work for chlamydia.
Laboratory NAAT (nucleic acid amplification test) is the clinical gold standard. It looks for chlamydia genetic material in a urine sample or a swab, with very high sensitivity and specificity, which is why clinics, Planned Parenthood, and primary-care offices rely on it. Sample types include urine, a vaginal self-swab or clinician-collected swab, a urethral swab, and (when relevant) a throat or rectal swab. Results usually come back in 1 to 3 days.
Rapid lateral-flow tests, including the at-home swab kits this site sells, use a different chemistry. They detect chlamydia antigens directly on a test strip and give a result in about 15 minutes, with no clinic visit and full privacy. They are not the same chemistry as a lab NAAT, and head-to-head sensitivity is generally somewhat lower for asymptomatic infections. They suit screening, partner follow-up, and quick reassurance, with the option to confirm a positive at a clinic. If you are not sure exactly what you were exposed to, broader at-home STI test kits screen for several common infections in a single panel.
A negative on either test is not absolute certainty if you tested too early in the window or were exposed at a non-genital site. A positive on a rapid test is worth confirming with a lab NAAT, and treatment should start promptly.
Test at least 14 days after exposure for either technology to be reliable. Earlier than that, the bacterial load may be too low to trigger a positive. If a test is negative within the first week and exposure is still a concern, retesting after day 14 is the safer call.
Lab NAAT (clinical gold standard). Highest sensitivity, results in 1 to 3 days, requires a clinic visit or mail-in sample. Can detect infection at urine, vaginal, urethral, throat, and rectal sites.
At-home rapid lateral-flow. Result in about 15 minutes, fully private, no clinic visit, somewhat lower sensitivity for asymptomatic genital infections, designed for screening rather than confirmatory diagnosis. A positive is worth confirming with a lab NAAT before starting treatment.
After a positive: treatment, retesting, and partner conversations
Chlamydia is curable, and treatment is straightforward. The CDC's current first-line recommendation is a 7-day course of doxycycline (100 mg twice daily). Azithromycin as a single 1 g dose is the recommended alternative when doxycycline is contraindicated, including during pregnancy (CDC, Chlamydia Treatment Guidelines). Many telehealth services can prescribe after a positive result without an in-person visit.
Where local laws permit, clinicians can also use expedited partner therapy, which provides antibiotics for the partner without requiring them to attend a separate appointment. This is one of the most effective ways to break ping-pong reinfection between partners.
The emotional layer is real. Many people describe a confusing mix of relief (it is treatable) and shame (it carries social weight that other infections do not). Both reactions are normal. The infection itself does not say anything about a person's character or relationship history.
- Avoid sex for 7 days after starting treatment, or until both partners have completed treatment, to prevent reinfection cycling between partners.
- Notify recent partners. The CDC recommends telling any sexual partner from the past 60 days, or your most recent partner if you have not had sexual contact in 60 days.
- Retest in 3 months. Reinfection from an untreated partner is the most common reason for a follow-up positive. The medication itself rarely fails when taken as prescribed.
- Test for co-infections. Chlamydia and gonorrhea travel together often enough that many clinicians treat presumptively for both. HIV and syphilis screening is also worth considering after any positive STI result.
Chlamydia during pregnancy
Pregnancy does not change the basic biology of chlamydia. The infection behaves the same way, with the same tendency toward silence and the same clinical presentations when symptoms appear. What changes is the stakes. Untreated chlamydia during pregnancy carries real risks for both the pregnant person and the baby, which is why routine chlamydia screening is a standard part of prenatal care in the U.S. for all pregnant women under 25 and those at increased risk at any age. The CDC also recommends rescreening in the third trimester for those under 25 or at elevated risk.
During delivery, active chlamydia can transmit to the baby, the most significant pregnancy-related risk. A baby born vaginally to a parent with active chlamydia is exposed to the bacteria at the cervix during birth. This can result in two well-documented complications: chlamydial conjunctivitis, a serious eye infection in the newborn typically appearing within the first two weeks of life, and neonatal chlamydial pneumonia, which develops several weeks after birth and can cause persistent coughing and breathing difficulties (WHO, Chlamydia Fact Sheet). Both are largely preventable when the infection is identified and treated before delivery.
Beyond transmission, chlamydia in pregnancy has been associated with preterm labor, premature rupture of membranes, low birth weight, and postpartum endometritis. A positive result during pregnancy is treated effectively and safely with antibiotics appropriate for use in pregnancy.
Untreated chlamydia at delivery can pass to a newborn during vaginal birth, causing chlamydial conjunctivitis (a serious eye infection appearing in the first two weeks of life) or neonatal pneumonia (developing several weeks after birth). Both are largely preventable when the infection is identified and treated before delivery, which is why prenatal screening is routine in the U.S.
The myths that keep people unscreened
A handful of beliefs delay testing more than anything else. Each one is worth correcting, because the cost of believing them is months of an infection no one is treating.
Most people who have chlamydia have no symptoms. If you do have symptoms, they may not appear until several weeks after you have sex with an infected partner.
FAQs
- Can chlamydia really cause no symptoms at all?
- Completely silent infection is the norm for this bacterium. Four out of five women and half of all men who carry it never notice anything; most diagnoses come from a routine screen, a partner's positive result, or a fertility workup, rather than from anything the person felt.
- What are the first signs of chlamydia?
- When symptoms appear at all, the earliest signs typically show up 7 to 21 days after exposure. For women, this is most often a subtle change in vaginal discharge (cloudier, a different color, or mildly unfamiliar). For men, it may be a small amount of discharge at the tip of the penis (especially noticeable in the morning) or a mild burning during urination. Both are easy to dismiss as minor irritation. The most common first sign, though, is no sign at all.
- How long after exposure should I wait to test?
- Wait at least 14 days after a possible exposure for the most reliable result. Both rapid at-home tests and lab NAATs perform best in the 1-to-3-week window. Testing in the first week risks a false negative because bacterial load is still low. If your result is negative before day 14 and you remain concerned, retest once you clear the two-week mark.
- Is what I'm feeling chlamydia or a UTI?
- The two overlap heavily because both can cause burning during urination. The clearest difference: UTIs usually do not cause genital discharge, and they are not transmitted sexually. UTIs typically also produce stronger urgency and frequency. If a course of UTI antibiotics does not resolve symptoms, or symptoms keep returning, ask for an STI panel rather than another UTI prescription.
- Will chlamydia clear up on its own?
- No. Chlamydia is a bacterial infection, and bacterial infections do not resolve without antibiotic treatment. Symptoms may fade temporarily, but the bacteria can persist in the body for months and continue causing damage. The only way to clear chlamydia is a short course of antibiotics, typically doxycycline for 7 days.
- Can I get chlamydia from oral or anal sex?
- Yes. Chlamydia can infect the throat after oral exposure and the rectum after anal exposure. Throat infections are often symptom-free or feel like a mild sore throat, and they require a throat swab to detect. Our at-home swab kit is validated for genital screening, so a throat or rectal exposure is a reason to ask a clinic for the right swab.
- Can untreated chlamydia really cause infertility?
- It can. In people with a uterus, untreated chlamydia is a leading bacterial cause of pelvic inflammatory disease, which can scar the fallopian tubes and increase the risk of ectopic pregnancy or infertility; the CDC estimates about 1 in 8 women with a history of PID later struggle to conceive. In people with testicles, untreated infection can cause epididymitis and, in rare cases, affect fertility. Risk accumulates the longer the infection stays untreated.
- Do I need to retest after treatment?
- Yes. The standard recommendation is a retest at 3 months. Reinfection from an untreated partner is the most common reason for a follow-up positive. The antibiotic course itself rarely fails when taken as prescribed. Make sure any partner from the past 60 days has been treated before resuming unprotected sex.
- U.S. Centers for Disease Control and Prevention. About chlamydia, including the often-asymptomatic nature of infection and the recommendation to screen sexually active women under 25.
- U.S. Centers for Disease Control and Prevention. Chlamydia treatment guidelines, including the first-line doxycycline 100 mg twice-daily 7-day regimen, the azithromycin alternative for pregnancy, partner-notification timeline, and expedited partner therapy.
- U.S. Centers for Disease Control and Prevention. Pelvic inflammatory disease overview, including the link to untreated chlamydia and the figure that about 1 in 8 women with a history of PID have difficulty getting pregnant.
- World Health Organization. Chlamydia fact sheet, including transmission routes, asymptomatic nature, neonatal conjunctivitis and pneumonia after vaginal delivery, and facilitation of HIV transmission.
- U.K. National Health Service. Chlamydia patient information, including specific symptom descriptions (unusual discharge and burning on urination) for women and men.
- NIH InformedHealth (IQWiG). Overview of chlamydia, including the asymptomatic-rate figures of about 80% in women and 50% in men.
- HIV.gov. CDC release of 2024 national STI surveillance data, including the roughly 8% year-over-year decline in reported chlamydia cases, a second consecutive year of decline.
